4//SEC Filing
HORNER GEORGE F III 4
Accession 0001181431-12-042331
CIK 0001544116other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 6:02 PM ET
Size
12.6 KB
Accession
0001181431-12-042331
Insider Transaction Report
Form 4
HORNER GEORGE F III
Director
Transactions
- Conversion
Common Stock
2012-07-24+56,103→ 71,728 total - Conversion
Series A Convertible Preferred Stock
2012-07-24−448,825→ 0 total→ Common Stock (56,103 underlying) - Conversion
Common Stock
2012-05-01$0.96/sh+15,625$15,000→ 15,625 total - Conversion
Stock Option (right to buy)
2012-05-01$0.96/sh−15,625$15,000→ 15,625 totalExercise: $0.96Exp: 2020-03-25→ Common Stock (15,625 underlying) - Purchase
Series A Convertible Preferred Stock
2012-03-15$1.00/sh+127,907$127,907→ 448,825 total→ Common Stock (15,988 underlying)
Footnotes (3)
- [F1]The Series A Preferred Stock had no expiration date and each share of Series A Preferred Stock converted automatically into approximately 0.125 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.
- [F2]Reflects a one-for-8.0000 reverse stock split that became effective on July 6, 2012.
- [F3]This option was granted on March 26, 2010 with respect to 31,250 shares of Common Stock, with 25% vesting on March 1, 2011 and the remaining 75% vesting in 36 substantially equal monthly installments beginning on April 31, 2011. This option was exercised with respect to 15,625 shares of Common Stock on May 1, 2012.
Documents
Issuer
Durata Therapeutics, Inc.
CIK 0001544116
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001120465
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 6:02 PM ET
- Size
- 12.6 KB